Pulmonary Rehabilitation and Asthma

Asthma is a chronic inflammatory disease characterized by airflow limitation and variable respiratory symptoms. It is characterized by variable symptoms such as cough, wheeze, chest tightness, and shortness of breath which vary in intensity and time. In order to reach a comprehensive approach of dis...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology Vol. 11; p. 542
Main Authors: Zampogna, Elisabetta, Zappa, Martina, Spanevello, Antonio, Visca, Dina
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 06.05.2020
Subjects:
asthma
chronic disease
exercise training
Pharmacology
pulmonary rehabilitation
treatment
treatment
asthma
pulmonary rehabilitation
chronic disease
exercise training
ISSN:1663-9812, 1663-9812
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Asthma is a chronic inflammatory disease characterized by airflow limitation and variable respiratory symptoms. It is characterized by variable symptoms such as cough, wheeze, chest tightness, and shortness of breath which vary in intensity and time. In order to reach a comprehensive approach of disease management, the importance of non-pharmacological treatment in addition to pharmacological therapy has been recently highlighted. Studies have documented that pulmonary rehabilitation has beneficial effects in patients with asthma, at any stage of the disease, improving exercise capacity, asthma control, and quality of life and reducing wheezing, anxiety, depression, and bronchial inflammation. Although several evidences suggest a role of pulmonary rehabilitation in patients with asthma, additional information is required to identify a specific program in order to improve clinical care based on specific patient's needs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Franco Pasqua, Istituto Riabilitativo Villa delle Querce, Italy; Francesco D’Abrosca, Independent Researcher, Novara, Italy
This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology
Edited by: Enrico M. Clini, University of Modena and Reggio Emilia, Italy
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.00542